|
About Us
Hemosure, Inc. is a privately held corporation headquartered
at El Monte, California, only 15 minutes away from downtown
Los Angeles. The Company is a pioneer in
the research and development of one-step rapid membrane tests.
It has been designated a registered GMP facility
for in vitro diagnostic medical devices by the FDA.
Hemosure is established upon over a decade of research
in the bio-technological industry. Its scientific professional
team has applied these years of R&D experience to their
development of one-step
membrane immunoassay tests. With the strong support of our
sister company,
WHPM, Hemosure
has continuously researched, developed, and produced high
quality rapid test systems that have not only revolutionized the
pharmaceutical industry, but have also set new industry standards
and guidelines.
Our current product
leader is
Hemosure®, a
trade name recognized worldwide in
immunological
fecal occult blood test (IFOBT). In year 2001, Hemosure was proudly designated a
sponsor in providing high quality immunological fecal
occult blood tests for a large colorectal cancer-screening program;
over 20,000 people in Beijing, China took part in the study.
In April 2004, the Company sponsored another colorectal cancer-screening
program in Hangzhou, China, in which over 60,000 people
participated. Upon completion, these two
recent studies
together will surpass any previous clinically related studies in the
world in terms of size and scope.
Through continuing clinical
development, Hemosure is committed to building a portfolio of quality
products. Using only the highest standards, we deliver our
products to the marketplace at highly
competitive and affordable prices. Our
mission
statement clearly identifies and sets the direction for
our company: "It is our goal to continually research and develop
novel tests systems to enhance the quality of life."
|
